We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$17.9B
AUM Growth
+$3.18B
Cap. Flow
+$2.11B
Cap. Flow %
11.82%
Top 10 Hldgs %
38.29%
Holding
721
New
293
Increased
98
Reduced
124
Closed
140

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$124M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$95.2M
3
PLRX icon
Pliant Therapeutics
PLRX
+$74.8M
4
MSFT icon
Microsoft
MSFT
+$72.6M
5
BMY icon
Bristol-Myers Squibb
BMY
+$56.6M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$123M
2
CTLT
CATALENT, INC.
CTLT
+$60.4M
3
EMR icon
Emerson Electric
EMR
+$55M
4
HD icon
Home Depot
HD
+$54.8M
5
CMCSA icon
Comcast
CMCSA
+$53.9M

Sector Composition

Rank Sector Weight
1 Healthcare 5.44%
2 Technology 2.51%
3 Communication Services 1.69%
4 Utilities 1.38%
5 Industrials 0.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOW icon
276
ServiceNow
NOW
$129B
$3.74M 0.02%
+33,290
New +$3.33M
QCOM icon
277
PUT
Qualcomm
QCOM
$176B
$3.74M 0.02%
31,400
-348,800
-92% -$40.1M
VMW
278
DELISTED
VMware, Inc
VMW
$3.66M 0.02%
25,497
-2,454
-9% -$318K
AUTL
279
Autolus Therapeutics
AUTL
$562M
$3.57M 0.02%
1,500,000
– –
IMA
280
ImageneBio Inc
IMA
$64.6M
$3.4M 0.02%
43,130
-953
-2% -$68.3K
LVS icon
281
Las Vegas Sands
LVS
$29.6B
$3.31M 0.02%
+57,061
New +$3.38M
LRCX icon
282
Lam Research
LRCX
$390B
$3.19M 0.02%
+49,630
New +$2.8M
HAL icon
283
CALL
Halliburton
HAL
$26.6B
$3.17M 0.02%
96,000
-497,500
-84% -$15.7M
HAL icon
284
PUT
Halliburton
HAL
$26.6B
$3.15M 0.02%
+95,600
New +$3.02M
BLK icon
285
Blackrock
BLK
$176B
$3.13M 0.02%
+4,529
New +$3.03M
WVE icon
286
Wave Life Sciences
WVE
$1.2B
$3.02M 0.02%
828,838
-42,662
-5% -$172K
KRE icon
287
State Street SPDR S&P Regional Banking ETF
KRE
$4.57B
$2.99M 0.02%
73,300
+15,400
+27% +$632K
LOW icon
288
CALL
Lowe's Companies
LOW
$125B
$2.93M 0.02%
13,000
-158,200
-92% -$32.9M
ALB icon
289
Albemarle
ALB
$15.5B
$2.92M 0.02%
+13,111
New +$2.68M
TCRT icon
290
Alaunos Therapeutics
TCRT
$4.86M
$2.92M 0.02%
38,137
– –
ZS icon
291
CALL
Zscaler
ZS
$27.3B
$2.87M 0.02%
+19,600
New +$2.39M
NKE icon
292
Nike
NKE
$61.9B
$2.85M 0.02%
+25,857
New +$3.02M
AZO icon
293
AutoZone
AZO
$51.1B
$2.81M 0.02%
+1,128
New +$2.88M
ATOS icon
294
Atossa Therapeutics
ATOS
$23.5M
$2.8M 0.02%
148,387
– –
MMM icon
295
3M
MMM
$94.3B
$2.78M 0.02%
+33,275
New +$2.83M
ABNB icon
296
CALL
Airbnb
ABNB
$107B
$2.78M 0.02%
21,700
-125,300
-85% -$14.7M
LCTX icon
297
Lineage Cell Therapeutics
LCTX
$278M
$2.77M 0.02%
1,966,247
-411,693
-17% -$569K
UAL icon
298
CALL
United Airlines
UAL
$42.1B
$2.77M 0.02%
+50,400
New +$2.38M
PG icon
299
Procter & Gamble
PG
$339B
$2.73M 0.02%
18,019
+15,397
+587% +$2.32M
DELL icon
300
Dell
DELL
$293B
$2.67M 0.02%
+49,385
New +$2.27M
10 11
12
13 14

Similar funds

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Laurion Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Laurion Capital Management held 721 positions worth $17.9B, up 22% from $14.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Laurion Capital Management deployed $2.11B of net new capital in Q2 2023, opening 293 new positions and adding to 98 existing holdings. Its largest new stake was Pliant Therapeutics: 3,158,570 shares worth $57.2M.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 6.6% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Viatris, an estimated $123M trimmed.

  • Laurion Capital Management's largest Q2 2023 buy was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
  • Laurion Capital Management added most to T-Mobile US in Q2 2023, an estimated $124M increase.
  • Laurion Capital Management's biggest Q2 2023 reduction was Viatris, cutting an estimated $123M.
  • Laurion Capital Management fully exited CATALENT, INC. in Q2 2023, selling an estimated $60.4M.
  • Laurion Capital Management's ten largest holdings make up 38% of its $17.9B portfolio in Q2 2023.
  • Laurion Capital Management opened 293 new positions and closed 140 in Q2 2023.
  • Laurion Capital Management's portfolio value rose 22% quarter-over-quarter to $17.9B.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.